NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

FDA Delays Cingulate’s ADHD Drug Approval – But No Safety or Efficacy Issues

FDA asked Cingulate to fix manufacturing details for ADHD drug; no safety issues. Company will update and resubmit soon.

FDA Delays Cingulate’s ADHD Drug Approval – But No Safety or Efficacy Issues
Credit: Valerie Plesch/Bloomberg
Already have an account? Sign in.
06/02/2026 · 10:11 AM
CING
/ Read more

Feed↓

NVIDIA Cuts Intel Stake by 25%, Portfolio Falls to $48.3 Billion in Latest 13F
Featured/ 11/16/2026 · 5:46 PM

NVIDIA Cuts Intel Stake by 25%, Portfolio Falls to $48.3 Billion in Latest 13F

NVIDIA’s September 2026 13F reveals a smaller $48.3B portfolio, led by SpaceX after a major reduction in its Intel stake from the prior quarter.

/ Subscriber only
Rosemont Pharmaceuticals to Acquire Aytu BioPharma in $2.70 All-Cash Tender Offer
Featured/ 11/16/2026 · 5:20 PM

Rosemont Pharmaceuticals to Acquire Aytu BioPharma in $2.70 All-Cash Tender Offer

Rosemont aims to expand its U.S. specialty pharma presence.

/ Subscriber only
Kalshi to Launch Stock Trading After Acquiring Broker, Pressuring Robinhood Shares
Featured/ 11/16/2026 · 3:35 PM

Kalshi to Launch Stock Trading After Acquiring Broker, Pressuring Robinhood Shares

Kalshi acquired a New York broker and plans to launch stock and ETF trading within two months, pressuring shares of Robinhood and Bullish.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI